Growth hormone treatment in pediatric burns: A safe therapeutic approach

Annals of Surgery

Volumn 228, Issue 4, 1998, Pages 439-448

  Ramirez, Roque J ^a   Wolf, Steven E ^a   Barrow, Robert E ^a   Herndon, David N ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ELECTROLYTE; GLUCOSE; HUMAN GROWTH HORMONE; INSULIN; PHOSPHORUS; PLACEBO; SERUM ALBUMIN;

ADOLESCENT; BODY SURFACE; BURN; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE BALANCE; HEMODYNAMICS; HORMONAL THERAPY; HUMAN; HYPERGLYCEMIA; HYPOALBUMINEMIA; HYPOCALCEMIA; INFECTION; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROTEIN DEPLETION; RANDOMIZED CONTROLLED TRIAL; WOUND HEALING;

ADOLESCENT; BURNS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; GROWTH HORMONE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES;

EID: 0032471179     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199810000-00001     Document Type: Conference Paper

References (34)

1. Pointing GA, Halliday D, Teale JD, et al. Postoperative nitrogen balance with intravenous hyponutrition and growth hormone. Lancet 1988;1: 438-439.
2. Byme TA, Morrissey TB, Gatzen C, et al. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation. Ann Surg 1993;218: 400-418.
3. Petersen SR, Holaday NJ, Jeevanandam M. Enhancement of protein synthesis efficiency in parenterally fed trauma victims by adjuvant recombinant human growth hormone. J Trauma 1994;36: 726-733.
4. Douglas RG, Humberstone DA, Haystead A, Shaw JH. Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition. Br J Surg 1990;77: 785-790.
5. Voerman HJ, van Schijndel RJMS, Groenveld ABJ, et al. Effects of recombinant human growth hormone in patients with severe sepsis. Ann Surg 1992;216: 648-655.
6. Knox J, Demling R, Wilmore D, et al. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J Trauma 1995;39: 526-532.
7. Herndon DN, Barrow RE, Kunkel KR, et al. Effects of recombinant human growth hormone on donor site healing in severely burned children. Ann Surg 1990;212:424-431.
8. Gilpin DA, Barrow RE, Rutan RL, et al. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 1994;220: 19-24.
9. Herndon DN, Hawkins HK, Nguyen TT, et al. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 1995;221: 649-659.
10. Herndon DN, Barrow RE, Kunkel KR, et al. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990;211: 424-431.
11. Gilpin DA, Herndon DN, Rutan RL, et al. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg 1994;220: 19-24.
12. Gore DC, Honeycutt D, Jahoor F, et al. Effect of exogenous growth hormone on whole-body and isolated limb protein kinetics in burned patients. Arch Surg 1991;126: 38-43.
13. Fleming RY, Rutan RL, Jahoor F, et al. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma 1992;32: 608-702.
14. Public Communications from Pharmacia & Upjohn Pharmaceuticals and Rolf Gunnarsson, MD to all industry and medical community involved with the use or potential use of recombinant human growth hormone, Oct. 31, 1997.
15. Hildreth MA, Herndon DN, Desai MH, Duke MA. Caloric needs of adolescent patients with burns. J Burn Care Rehabil 1989;10: 523-526.
16. Hildreth MA, Herndon DN, Desai MH, Broemeling LD. Current treatment reduces calories required to maintain weight in pediatric patients with burns. J Burn Care Rehabil 1990;11: 405-409.
17. Wolf SE, Rose JK, Desai M, et al. Mortality determinants in massive pediatric burns: an analysis of 103 children with ≥80% TBSA burns (≥70% full-thickness). Ann Surg 1997;225: 554-569.
18. Fleming RY, Rutan RL, Jahoor F, et al. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma 1992;32: 608-702.
19. Aarsland A, Chinkes D, Wolfe RR, et al. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged. Ann Surg 1996;223: 777-789.
20. Gobel FL, Nordstrom LA, Nelson RR. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation 1978;57: 549-556.
21. Baller D, Bretschneider HJ, Hellige G. Validity of myocardial oxygen consumption parameters. Clin Cardiol 1979;2: 317-327.
22. Rooke GA, Feigl EO. Work as a correlate of canine left ventricular oxygen consumption, and the problem of catecholamine oxygen wasting. Circ Res 1982;50:273-286.
23. th International Congress on the Immune Consequences of Trauma, Shock and Sepsis - Mechanisms and Therapeutic Approaches; 1997 Mar 4-8; Munich, Germany.
24. Aarsland A, Chinkes DL, Wolfe RR, et al. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone: rate of hepatic VLDL triglyceride secretions remains unchanged. Ann Surg 1996;23(6): 777-789. Ann Surg 1996;223: 777-789.
25. Aarsland A, Chinkes DL, Wolfe RR, et al. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone: rate of hepatic VLDL triglyceride secretions remains unchanged. Ann Surg 1996;23(6): 777-789. Ann Surg 1996;223: 777-789.
26. Aarsland A, Chinkes DL, Wolfe RR, et al. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone: rate of hepatic VLDL triglyceride secretions remains unchanged. Ann Surg 1996;23(6): 777-789.
27. Gore DC, Honeycutt D, Jahoor F, et al. Effect of exogenous growth hormone on glucose utilization in burn patients. J Surg Res 1991;51: 518-523.
28. McMahon MM, Bistrtrian BR. Host defenses ans susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995;9(1): 1-9.
29. Eliashiv A, Olumide F, Norton L, et al. Depression of cell-mediated immunity in diabetes. Arch Surg 1978;113(10): 1180-1183.
30. Sakurai Y, Aarsland A, Herndon DN, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 1995;222: 283-297.
31. Pierre EJ, Barrow RE, Hawkins HK, et al. Effects of insulin on wound healing. J Trauma 1998;44(2): 342-345.
32. Jarrar D, Wolf SE, Jeschke M, et al. Growth Hormone Attenuates the Acute Phase Response to Thermal Injury. Arch Surg 1997;132:1171-1176.
33. Fleming RY, Rutan RL, Jahoor F, et al. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma 1992;32: 608-702.
34. Gore DC, Honeycutt D, Jahoor F, et al. Effect of exogenous growth hormone on glucose utilization in burn patients. J Surg Res 1991;51: 518-523.